dr. pegram on developing agents for patients with her2 breast cancer and brain metastases
Published 6 years ago • 154 plays • Length 1:18Download video MP4
Download video MP3
Similar videos
-
1:56
dr. lin on developing systemic therapies for patients with brain metastases in her2 breast cancer
-
1:22
dr. pegram on challenges facing the treatment of her2-positive breast cancer
-
1:53
dr. pegram on pertuzumab combination for her2-positive breast cancer
-
2:03
dr. pegram on promising novel agents in her2 metastatic breast cancer
-
3:44
her2 breast cancer: brain metastasis prevalence & later-line therapy
-
2:02
dr. pegram on early treatment with t-dm1
-
1:12
dr. pegram on challenges in neoadjuvant treatment for her2-positive breast cancer
-
2:55
audio described: clinical trial tests nivolumab for patients with rare brain and spine cancers
-
1:30
dr. czerniecki on treatment options for patients with her2 brain metastases
-
1:07
dr. anders on systemic agents for patients with breast cancer and brain mets
-
5:21
study of neratinib for patients with her2-positive breast cancer with brain metastases
-
3:30
2020 peaprogram breast cancer series patients with brain metastases - prognosis & impact on survival
-
5:37
therapeutic landscape for patients with her2-positive breast cancer with active brain metastases
-
3:45
her2climb: implications for brain metastases in her2 mbc
-
1:19
dr. pegram discusses the use of neratinib in her2 breast cancer
-
1:36
dr. mortimer on brain metastases in her2 breast cancer
-
1:07
dr. freedman on preventing brain metastases in her2 breast cancer
-
1:28
dr. dawar on challenges with neratinib in metastatic her2 breast cancer
-
2:30
dr. pegram on neoadjuvant treatments for her2-postive breast cancer